Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New genes for regulating the heart rhythm discovered

02.07.2014

Cardiac arrhythmia is a frequent occurrence: according to the WHO, 33.5 million people all over the world are affected by atrial fibrillation - this being just one of many different kinds of arrhythmia.

A global research consortium, of which the EURAC Center for Biomedicine in Bozen-Bolzano is a member, has now identified 23 new genes which control both the heart rhythm and the length of the so-called QT interval. The study was further enhanced by data provided by participants from South Tyrol. The results, which open up new pathways for early diagnosis and treatment, have just been published in the medical journal “Nature Genetics”.

The QT interval is part of the heart’s electrical cycle as measured by ECG, and represents the electrical depolarization and repolarization of the ventricles. Lengthened intervals indicate dysfunction in the heart beat and are liable to lead to a five-fold increase in the risk of sudden death from heart failure. The underlying causes for such irregularities have not yet been fully explored. They are generally supposed to be due mainly to genetic factors.

In collaboration with research partners recruited from an international consortium, scientists from the EURAC Center for Biomedicine have evaluated the ECG results of over 100,000 study participants from Germany, Italy and the USA, as well as around 1,300 from South Tyrol who made their data freely available to the EURAC researchers. The scientists compared the QT intervals from the ECGs of all the study participants with their genetic variants in order to identify possible connections.

The result: they discovered 23 new genes which are linked to a lengthened QT interval. At the same time, they were able to demonstrate that the newly identified genes, which previously had not been thought to play a part in the heart rhythm, had a significant influence on the electrical activity of the heart muscle. In more in-depth studies with heart disease patients, the researchers could additionally determine that two of the newly identified genes were indeed risk factors for the disease known as “Long QT syndrome”.

“We still need to look more closely at the interplay of these genes with other risk factors, such as medication or life style. But one thing is certain: these findings have definitely brought us a great deal closer to recognising the causes of arrhythmia and sudden death from heart failure,” stress the two scientists Peter Pramstaller, manager of the EURAC Center for Biomedicine and his deputy, Andrew Hicks.

“With data from more than 100,000 participants in the study and the joint efforts of hundreds of international researchers, this represents one of the biggest global research projects on this topic to which we were able to contribute through both our scientific expertise as well as making data available from South Tyrol participants,” summarise Pramstaller and Hicks.

Another current study carried out by the EURAC Center for Biomedicine will provide further important insights into arrhythmia and sudden death from heart failure. Here, researchers are examining a protein, also identified in the QT study, which transports calcium within the cells in a pump-like action and can therefore be considered one of the most important proteins for a correctly functioning heart cell.

Weitere Informationen:

http://www.nature.com/ng/journal/vaop/ncurrent/full/ng.3014.html - Article "Nature Genetics"

Laura Defranceschi | idw - Informationsdienst Wissenschaft
Further information:
http://www.eurac.edu

Further reports about: ECG EURAC Genetics Nature death depolarization genes identify medication rhythm

More articles from Health and Medicine:

nachricht Modeling NAFLD with human pluripotent stem cell derived immature hepatocyte like cells
30.06.2016 | Heinrich-Heine University Duesseldorf

nachricht Heat for wounds – water-filtered infrared-A (wIRA) assists wound healing
30.06.2016 | Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Thousands on one chip: New Method to study Proteins

Since the completion of the human genome an important goal has been to elucidate the function of the now known proteins: a new molecular method enables the investigation of the function for thousands of proteins in parallel. Applying this new method, an international team of researchers with leading participation of the Technical University of Munich (TUM) was able to identify hundreds of previously unknown interactions among proteins.

The human genome and those of most common crops have been decoded for many years. Soon it will be possible to sequence your personal genome for less than 1000...

Im Focus: Optical lenses, hardly larger than a human hair

3D printing enables the smalles complex micro-objectives

3D printing revolutionized the manufacturing of complex shapes in the last few years. Using additive depositing of materials, where individual dots or lines...

Im Focus: Flexible OLED applications arrive

R2D2, a joint project to analyze and development high-TRL processes and technologies for manufacture of flexible organic light-emitting diodes (OLEDs) funded by the German Federal Ministry of Education and Research (BMBF) has been successfully completed.

In contrast to point light sources like LEDs made of inorganic semiconductor crystals, organic light-emitting diodes (OLEDs) are light-emitting surfaces. Their...

Im Focus: Unexpected flexibility found in odorant molecules

High resolution rotational spectroscopy reveals an unprecedented number of conformations of an odorant molecule – a new world record!

In a recent publication in the journal Physical Chemistry Chemical Physics, researchers from the Max Planck Institute for the Structure and Dynamics of Matter...

Im Focus: 3-D printing produces cartilage from strands of bioink

Strands of cow cartilage substitute for ink in a 3D bioprinting process that may one day create cartilage patches for worn out joints, according to a team of engineers. "Our goal is to create tissue that can be used to replace large amounts of worn out tissue or design patches," said Ibrahim T. Ozbolat, associate professor of engineering science and mechanics. "Those who have osteoarthritis in their joints suffer a lot. We need a new alternative treatment for this."

Cartilage is a good tissue to target for scale-up bioprinting because it is made up of only one cell type and has no blood vessels within the tissue. It is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Quantum technologies to revolutionise 21st century - Nobel Laureates discuss at Lindau

30.06.2016 | Event News

International Conference ‘GEO BON’ Wants to Close Knowledge Gaps in Global Biodiversity

28.06.2016 | Event News

ERES 2016: The largest conference in the European real estate industry

09.06.2016 | Event News

 
Latest News

Modeling NAFLD with human pluripotent stem cell derived immature hepatocyte like cells

30.06.2016 | Health and Medicine

Rice University lab runs crowd-sourced competition to create 'big data' diagnostic tools

30.06.2016 | Life Sciences

A drop of water as a model for the interplay of adhesion and stiction

30.06.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>